Antimicrobial Activity of Two Mouthwashes

Sponsor
Universidade do Vale do Sapucai (Other)
Overall Status
Completed
CT.gov ID
NCT02375178
Collaborator
(none)
30
3
16

Study Details

Study Description

Brief Summary

This is a three arm randomized trial. The aim is to evaluate the antimicrobial activity of chlorhexidine and polyhexamethylene biguanide oral antiseptics on the microorganisms of the oral cavity. A total of 30 healthy volunteers will be enrolled and randomly allocated to control group (CG, n=10), which will be instructed to rinse the mouth with 10ml of a sterile saline solution for one minute, to chlorhexidine group (ClG, n=10), which will be instructed to rinse the mouth with 10ml of an 0.12% chlorhexidine solution, for one minute, or to polyhexamethylene biguanide group (PG, n=10), which will be instructed to rinse the mouth with 10ml of an 0.07% polyhexamethylene biguanide solution, for one minute. Samples of saliva will be collected before the mouth wash and after 30, 60 and 180 minutes. Samples will be plated on manitol agar, mitis salivarius agar, EMB agar and Sabouraud agar. Samples will be processed by a blinded microbiologist.

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Antimicrobial Activity of Two Mouthwashes
Study Start Date :
Aug 1, 2014
Actual Primary Completion Date :
Oct 1, 2014
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Sterile saline solution

sterile Saline solution 0,9%

Drug: Sterile saline solution
The volunteers will be instructed to mouthwash with 10ml of a sterile saline solution for 30 seconds and than make the mouthwash with 10ml of a sterile saline solution. Samples of saliva will be collected before the mouth wash and after 30, 60 and 180 minutes.

Experimental: chlorhexidine

chlorhexidine 0,12% mouthwash

Drug: chlorhexidine
The volunteers will be instructed to mouthwash with 10ml of a sterile saline solution for 30 seconds and than make the mouthwash with 10ml of an 0.12% chlorhexidine solution. Samples of saliva will be collected immediately before the mouth wash and after 30, 60 and 180 minutes.

Drug: Sterile saline solution
The volunteers will be instructed to mouthwash with 10ml of a sterile saline solution for 30 seconds and than make the mouthwash with 10ml of a sterile saline solution. Samples of saliva will be collected before the mouth wash and after 30, 60 and 180 minutes.

Experimental: polyhexamethylene

polyhexamethylene biguanide 0,07% mouthwash

Drug: Polyhexamethylene biguanide
The volunteers will be instructed to mouthwash with 10ml of a sterile saline solution for 30 seconds and than make the mouthwash with 10ml of an 0,07% solution Polyhexamethylene biguanide. Samples of saliva will be collected before the mouth wash and after 30, 60 and 180 minutes.

Drug: Sterile saline solution
The volunteers will be instructed to mouthwash with 10ml of a sterile saline solution for 30 seconds and than make the mouthwash with 10ml of a sterile saline solution. Samples of saliva will be collected before the mouth wash and after 30, 60 and 180 minutes.

Outcome Measures

Primary Outcome Measures

  1. Number of Colony Forming Units [180 minutes]

    Samples of saliva will be collected before the mouth wash and after 30, 60 and 180 minutes.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • patients aged 18-30 years
Exclusion Criteria:
  • patients with a hypersensitivity or allergic response by some component of the formula antiseptics,

  • pregnant women,

  • lactating,

  • history of periodontal disease,

  • smoking,

  • decompensated diabetics,

  • patients undergoing chemotherapy,

  • radiotherapy patient,

  • transplanted patient and refuses to participate,

  • not signing a term of free and informed concentiment

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Universidade do Vale do Sapucai

Investigators

  • Study Chair: Daniela Veiga, MD,PhD, Universidade do Vale do Sapucai

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fernanda Sebba de Souza, student, Universidade do Vale do Sapucai
ClinicalTrials.gov Identifier:
NCT02375178
Other Study ID Numbers:
  • MCAS antisseptico oral
First Posted:
Mar 2, 2015
Last Update Posted:
Jan 10, 2017
Last Verified:
Jan 1, 2017

Study Results

No Results Posted as of Jan 10, 2017